Retinol and Bakuchiol are both present in the ingredient list. All Vitamin A derivatives, including Retinol, carry a mandatory pregnancy contraindication and should not be used during pregnancy or when trying to conceive. This must be clearly communicated on packaging. The aqueous cream base introduces water, which accelerates Retinol degradation compared to a water-free formula, reducing active potency over the product's shelf life. The most significant concern from the public ingredient list is the combination of Retinol and Parfum in a daily leave-on product. Retinol speeds up cell turnover and gradually thins the outer skin layer during the adjustment phase, which can make the skin temporarily more permeable. Applying an undisclosed fragrance blend to skin in this state carries a higher sensitisation risk than fragrance in a standard moisturiser. No individual fragrance allergen components are named. No banned substances, no restricted parabens, no formaldehyde releasers.

Retinol and Bakuchiol together have published clinical support. A 2019 study in the British Journal of Dermatology found Bakuchiol comparable to Retinol for fine line reduction with fewer side effects. Their combination may offer a complementary benefit. The cream vehicle makes this more accessible for cautious users than a high-potency serum, which suits a mainstream accessible brand. However, the aqueous base reduces Retinol stability compared to a water-free formulation. If the cream is packaged in a jar, repeated air exposure on opening would introduce additional oxidation risk. Tocopheryl Acetate provides some antioxidant stabilisation in the formula, but this does not fully compensate for the water-based vehicle. Phenoxyethanol and Ethylhexylglycerin provide adequate preservation. Retinol and Bakuchiol concentrations are both undisclosed, which means active plausibility cannot be confirmed from public data alone.

Retinol and Bakuchiol are confirmed present in the ingredient list. Neither concentration is disclosed, which is the primary evidence gap in this product. For a Retinol product, the concentration determines how to introduce it, how quickly to expect results, and how severe the adjustment period may be. Without a disclosed concentration, the Youth Boost claim cannot be calibrated or verified from public evidence. No published test reports for anti-ageing efficacy, dermatologist testing, or clinical results are publicly accessible. MADE SAFE certified. The combination of Retinol with undisclosed Parfum is a consumer information gap that the brand's toxin-free positioning does not address.

Full INCI on mamaearth.in, consistent across Nykaa. The pregnancy contraindication for Retinol should be prominently communicated as a safety requirement. Retinol concentration is not disclosed, which is the single most important piece of consumer information for a retinol product. Bakuchiol concentration is also not disclosed. Parfum listed without individual compound names. No published test reports. Grade C: some transparency through INCI disclosure and third-party certification, but no lab name, method, or clinical result for any claim is publicly visible.

Night-use-only guidance is present. Application frequency and skin type guidance are communicated. The pregnancy contraindication for Retinol is required and should be prominently displayed. A note about gradually introducing the product and using SPF the following morning is important for consumers unfamiliar with retinoids and would strengthen consumer clarity.